DiaMedica Therapeutics (DMAC) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

DMAC is expected to report earnings to rise 25.62% to -16 cents per share on November 06

DiaMedica Therapeutics DMAC Stock Earnings Reports

Q3'24

Est.

$-0.16

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.02

Q3'23

Beat

by $0.01

The last earnings report on August 07 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 31.66K shares outstanding, the current market capitalization sits at 178.69M.

View a ticker or compare two or three

Compare

DMAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For DMAC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DMAC (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

301 Carlson Parkway

Phone

+1 763 496-5454

Employees

Web

https://www.diamedica.com